Lyon, France
Boehringer Ingelheim opened its $81 million global center for veterinary vaccine development in October of 2018. Located in Lyon, France, the four-story, 156,000-sf facility provides research and development laboratories for the creation of animal vaccines for diseases such as rabies and avian influenza. Designed as an international center for biological excellence, the project features scalable production suites and can accommodate 200 employees. Boehringer Ingelheim is also building an adjacent $75 million formulation and filling plant on its Lyon campus; occupancy is expected in spring of 2020.
